ID: ALA463391

Max Phase: Preclinical

Molecular Formula: C19H23FN3O8P

Molecular Weight: 471.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@H](n2cccnc2=O)[C@@H](F)[C@@H]1O)Oc1ccccc1

Standard InChI:  InChI=1S/C19H23FN3O8P/c1-12(18(25)28-2)22-32(27,31-13-7-4-3-5-8-13)29-11-14-16(24)15(20)17(30-14)23-10-6-9-21-19(23)26/h3-10,12,14-17,24H,11H2,1-2H3,(H,22,27)/t12-,14+,15-,16+,17+,32?/m0/s1

Standard InChI Key:  LXWLBMJUHGIEPQ-BORMQNQCSA-N

Associated Targets(Human)

CFPAC-1 421 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T-24 2342 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 471.38Molecular Weight (Monoisotopic): 471.1207AlogP: 1.19#Rotatable Bonds: 9
Polar Surface Area: 138.21Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.24CX Basic pKa: CX LogP: 0.44CX LogD: 0.44
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.41Np Likeness Score: 0.10

References

1. Yoo CB, Valente R, Congiatu C, Gavazza F, Angel A, Siddiqui MA, Jones PA, McGuigan C, Marquez VE..  (2008)  Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine.,  51  (23): [PMID:19006382] [10.1021/jm8005965]

Source